DeGrace, Shane
Turk, Norman
Alhoch, Yasmine
Duru, O. Kenrik
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 17 January 2024
Accepted: 12 November 2025
First Online: 27 November 2025
Declarations
:
: This study was approved by the Institutional Review Board at the University of California, Los Angeles (IRB# 20–000583). The research was conducted in accordance with the NIH Guiding Principles of Ethical Research.
: Not applicable.
: Dr. O. Duru is a consultant for ExactCare Pharmacy, Inc and Boehringer Ingelheim. There are no other potential conflicts reported by study authors.